We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant.
- Authors
Şıklar, Zeynep; Ellard, Sian; Okulu, Emel; Berberoğlu, Merih; Young, Elizabeth; Erdeve, Şenay Savaş; Mungan, İlke Akın; Hacıhamdioğlu, Bülent; Erdeve, Ömer; Arsan, Saadet; Öçal, Gönül
- Abstract
Neonatal diabetes mellitus (NDM) is a rare condition that can be either transient or permanent. KATP channel (Kir6.2 or SUR1) mutation, chromosome 6 abnormalities, insulin, or glucokinase gene mutations can lead to isolated NDM. Cases caused by Kir6.2 mutation usually result in permanent NDM (PNDM) rather than transient NDM (TNDM). The majority of patients with the Kir6.2 or SUR1 mutation can be successfully managed with a sulfonylurea agent, without the need for insulin. We report a preterm male with NDM having two novel missense mutations, E322A and D352H, in the KCNJ11 gene. At 2 months of age, successful transition from insulin to glibenclamide (glyburide) therapy of the patient was managed. At 5 months of age, his diabetes went in to remission.
- Subjects
NEONATAL diseases; DIABETES in children; GENETIC mutation; INSULIN; GLIBENCLAMIDE
- Publication
Journal of Pediatric Endocrinology & Metabolism, 2011, Vol 24, Issue 11/12, p1077
- ISSN
0334-018X
- Publication type
Article
- DOI
10.1515/JPEM.2011.250